

FMCSA Drug & Alcohol Clearinghouse- Sept 2026 Data Analysis
The Federal Motor Carrier Safety Administration (FMCSA) Commercial Driver's License (CDL) Drug and Alcohol Clearinghouse serves as an essential nationwide online database. It provides real-time access to information regarding drug and alcohol program violations by CDL and Commercial Learner's Permit (CLP) holders. Established under 49 C.F.R. § 382.705, the Clearinghouse mandates that employers, Consortia/Third-Party Administrators (C/TPAs), and Medical Review Officers (MROs) report positive drug and alcohol test results, test refusals, and actual knowledge violations.
This comprehensive analysis evaluates data updated as of October 1, 2026, incorporating full historical performance from January 6, 2020, through the Year-To-Date (YTD) partial analysis of September 2026.
Since its official launch on January 6, 2020, the Clearinghouse has fundamentally altered regulatory compliance and oversight across the U.S. commercial motor vehicle (CMV) transportation sector. Key cumulative totals and structural highlights as of October 1, 2026, include:
When a commercial driver incurs a drug or alcohol violation, federal law strictly prohibits them from operating a CMV until they fulfill the rigorous multi-step Return-to-Duty (RTD) sequence mandated by 49 C.F.R. Part 40. As of October 1, 2026, the 360,759 unique drivers with recorded violations are divided into two primary legal operational categories.
| Driver Status Category | Number of Drivers | % of Total Drivers |
|---|---|---|
| Drivers in 'Prohibited' Status (Barred from CMV Operation) | 218,977 | 60.70% |
| Drivers in 'Not-Prohibited' Status (Eligible for Safety-Sensitive Duties) | 141,782 | 39.30% |
To earn reinstatement to 'Not-Prohibited' status, a driver must receive a negative RTD test result. Once reinstated, the driver remains subject to a mandated follow-up testing plan designed by a Substance Abuse Professional (SAP):
A concerning trend in the September 2026 report is the vast majority of prohibited drivers who have made no formal effort to initiate or complete the RTD process. The 218,977 prohibited drivers are distributed across the following specific RTD stages:
| RTD Process Phase / Milestone | Driver Count | % of Prohibited | Step # |
|---|---|---|---|
| RTD Process Not Started (No SAP Request Filed) | 174,051 | 79.50% | Steps 0 |
| RTD Process Begun, Not Yet Eligible for RTD Testing | 20,524 | 9.40% | Steps 1–3 |
| Eligible for RTD Test, Test Not Yet Completed | 24,402 | 11.10% | Step 4 |
Regulatory Insight — The 6-Step Return-to-Duty Sequence:
The Clearinghouse tracks driver progression across six standardized milestones: (1) Initial SAP Request Sent, (2) SAP Designated, (3) Initial SAP Assessment Completed, (4) Driver Determined Eligible for RTD Test, (5) RTD Test with Negative Result (Lifts Prohibition), and (6) Follow-Up Testing Plan Completed. The fact that 79.5% (174,051 drivers) have not even taken Step 1 indicates significant career attrition, where drivers facing violations exit the regulated commercial driving sector rather than undergo substance rehabilitation.
Annual violation data illustrates how reporting volumes scaled following the January 2020 launch, peaked in 2022, and subsequently began a steady decline through 2026 YTD.
| Year | Drug Violations | Alcohol Violations | Total Violations | Peak Ref. (2022) |
|---|---|---|---|---|
| 2020 | 53,577 | 1,159 | 54,736 | 78.15% |
| 2021 | 58,419 | 1,433 | 59,852 | 85.45% |
| 2022 (Peak) | 68,522 | 1,518 | 70,040 | 100.00% |
| 2023 | 68,379 | 1,610 | 69,989 | 99.93% |
| 2024 | 61,815 | 1,701 | 63,516 | 90.69% |
| 2025 | 56,417 | 1,713 | 58,130 | 82.99% |
| 2026 (YTD)* | 39,945 | 1,301 | 41,246 | N/A (Partial) |
Source Note: *Note: 2026 YTD figures reflect partial data through September 30, 2026.
Federal regulations categorize drug and alcohol violations into three distinct legal reporting categories: Positive Test Results, Test Refusals, and Actual Knowledge Violations.
A. Drug Violations Breakdown (407,074 Total)
B. Alcohol Violations Breakdown (10,435 Total)
| Year | Drug Pos. | Drug Ref. | Drug AK | Alc .04+ | Alc Ref. | Alc AK |
|---|---|---|---|---|---|---|
| 2020 | 44,893 | 7,499 | 1,185 | 723 | 273 | 163 |
| 2021 | 49,073 | 8,378 | 968 | 876 | 321 | 236 |
| 2022 | 58,254 | 9,313 | 955 | 924 | 341 | 253 |
| 2023 | 54,779 | 12,696 | 904 | 1,035 | 313 | 262 |
| 2024 | 51,396 | 9,632 | 787 | 1,098 | 319 | 284 |
| 2025 | 48,080 | 7,545 | 792 | 1,059 | 338 | 316 |
| 2026 (YTD) | 34,415 | 4,946 | 584 | 825 | 260 | 216 |
System Marker — End of Session 1. Section 2 continues below with detailed substance breakdown, drug and alcohol test types, query statistics, and complete entity registration analysis.
Positive drug tests represent 82% of all reported violations. In many instances, a single urine specimen tests positive for multiple controlled substances. As of October 1, 2026, a total of 386,252 substance identifications have been recorded across 340,890 positive tests.
| Substance Identified | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026* | Trend | Total |
|---|---|---|---|---|---|---|---|---|---|
| Marijuana Metabolite | 32,016 | 28,916 | 34,901 | 37,603 | 39,321 | 32,939 | 24,078 | -5.6% | 229,774 |
| Cocaine Metabolite (BZE) | 9,049 | 7,871 | 10,349 | 10,077 | 10,561 | 9,082 | 6,128 | -9.9% | 63,117 |
| Methamphetamine (MET/MAMP) | 5,199 | 5,165 | 4,575 | 4,523 | 5,400 | 4,113 | 2,725 | -10.1% | 31,700 |
| Amphetamine (AMP) | 4,937 | 4,870 | 3,855 | 4,244 | 5,170 | 3,504 | 2,485 | -9.1% | 29,065 |
| Oxymorphone (OXYM) | 1,287 | 1,320 | 1,093 | 1,352 | 977 | 971 | 591 | -0.6% | 7,591 |
| Oxycodone (OXYC) | 1,060 | 1,058 | 1,088 | 921 | 803 | 814 | 496 | +1.4% | 6,240 |
| Hydrocodone (HYC) | 1,030 | 1,016 | 997 | 700 | 828 | 685 | 517 | -2.1% | 5,773 |
| Hydromorphone (HYM) | 916 | 942 | 917 | 714 | 807 | 733 | 495 | +2.7% | 5,524 |
| Morphine (MOP) | 373 | 424 | 388 | 370 | 417 | 379 | 266 | -2.3% | 2,617 |
| Codeine (COD) | 369 | 345 | 413 | 358 | 316 | 317 | 240 | +0.3% | 2,358 |
| 6-Acetylmorphine (6-AM) | 190 | 297 | 115 | 176 | 102 | 78 | 44 | -23.5% | 1,002 |
| Phencyclidine (PCP) | 123 | 133 | 92 | 77 | 131 | 75 | 59 | -2.6% | 690 |
| Ecstasy (MDMA) | 61 | 63 | 66 | 77 | 84 | 88 | 69 | +4.8% | 508 |
| Methylenedioxyamphetamine (MDA) | 35 | 27 | 53 | 50 | 44 | 44 | 40 | -17.0% | 293 |
| All Substances Total | 56,645 | 52,469 | 58,822 | 61,430 | 65,021 | 53,822 | 38,233 | -6.6% | 386,252 |
Note: *2024–2025 Trend % Change reflects full annual comparison prior to 2026 YTD analysis.
Dilute Specimen Tracking: In addition to identified substances, MROs have reported 17,083 total dilute specimens since 2020, with 1,625 dilute specimens recorded in 2026 YTD.
Understanding the specific test types that catch drug and alcohol violations provides critical intelligence for fleet safety directors.
| Year | Pre-Emp. | Random | Post-Acc. | Reas. Susp. | RTD | Follow-Up | Total |
|---|---|---|---|---|---|---|---|
| 2020 | 27,688 | 19,904 | 2,132 | 824 | 678 | 1,166 | 52,392 |
| 2021 | 32,649 | 18,932 | 2,060 | 853 | 1,170 | 1,787 | 57,451 |
| 2022 | 39,851 | 20,067 | 2,573 | 912 | 1,550 | 2,614 | 67,567 |
| 2023 | 38,192 | 21,168 | 2,669 | 1,075 | 1,592 | 2,779 | 67,475 |
| 2024 | 33,089 | 19,625 | 2,544 | 1,132 | 1,740 | 2,898 | 61,028 |
| 2025 | 29,825 | 17,628 | 2,494 | 1,085 | 1,610 | 2,983 | 55,625 |
| 2026 (YTD) | 22,048 | 11,909 | 1,780 | 783 | 955 | 1,886 | 39,361 |
Drug Testing Analysis: Pre-Employment (223,342 tests / 55.7%) and Random Testing (129,233 tests / 32.2%) combined detect nearly 88% of all drug violations, serving as the primary gatekeepers for commercial fleet safety.
| Year | Pre-Emp. | Random | Post-Acc. | Reas. Susp. | RTD | Follow-Up | Total |
|---|---|---|---|---|---|---|---|
| 2020 | 38 | 549 | 103 | 259 | 10 | 37 | 996 |
| 2021 | 73 | 630 | 132 | 295 | 12 | 55 | 1,197 |
| 2022 | 52 | 674 | 124 | 334 | 10 | 71 | 1,265 |
| 2023 | 58 | 724 | 137 | 344 | 14 | 71 | 1,348 |
| 2024 | 56 | 729 | 130 | 422 | 13 | 67 | 1,417 |
| 2025 | 91 | 715 | 135 | 372 | 13 | 71 | 1,397 |
| 2026 (YTD) | 55 | 542 | 126 | 303 | 8 | 51 | 1,085 |
Alcohol Testing Analysis: Unlike drug testing, alcohol violations are overwhelmingly caught during Random Testing (4,563 tests / 52.4%) and Reasonable Suspicion Testing (2,329 tests / 26.8%). Pre-employment alcohol tests represent only 4.9% of violations.
Employers must query the Clearinghouse during pre-employment screening and conduct annual queries for all employed CDL drivers. Since 2020, 6,569,739 cumulative unique drivers have been queried.
| Year | Limited | Pre-Employment | Full (Other) | Total Queries | Unique Drivers |
|---|---|---|---|---|---|
| 2020 | 2,701,436 (63%) | 1,429,842 (33%) | 137,133 (3%) | 4,268,411 | 2,688,605 |
| 2021 | 4,229,582 (66%) | 2,025,466 (32%) | 161,736 (3%) | 6,416,784 | 3,220,679 |
| 2022 | 4,268,692 (61%) | 2,516,786 (36%) | 163,653 (2%) | 6,949,131 | 3,373,881 |
| 2023 | 4,307,007 (60%) | 2,638,157 (37%) | 189,458 (3%) | 7,134,622 | 3,512,376 |
| 2024 | 3,955,348 (58%) | 2,674,960 (39%) | 205,792 (3%) | 6,836,100 | 3,636,846 |
| 2025 | 3,517,837 (54%) | 2,748,799 (43%) | 197,648 (3%) | 6,464,284 | 3,670,860 |
| 2026 (YTD) | 2,361,354 (49%) | 2,347,369 (48%) | 136,596 (3%) | 4,845,319 | 2,731,749 |
Query Trend: Pre-Employment query proportions have grown steadily from 33% in 2020 to 48% in 2026 YTD, highlighting intensified hiring checks across the freight industry.
Active registration in the Clearinghouse is mandatory for motor carriers, drivers, and service agents. As of October 1, 2026, total registrations across all user categories stand at 11,900,794.
Clearinghouse Registrations by Organization Type (2020–2026 YTD)
| Year | Drivers | Employers | C/TPAs | MROs | SAPs | Annual Total |
|---|---|---|---|---|---|---|
| 2020 | 4,696,161 | 137,685 | 3,246 | 256 | 926 | 4,838,274 |
| 2021 | 1,499,034 | 85,131 | 3,341 | 260 | 790 | 1,588,556 |
| 2022 | 746,949 | 76,529 | 2,864 | 244 | 746 | 827,332 |
| 2023 | 603,666 | 71,069 | 2,763 | 182 | 677 | 678,357 |
| 2024 | 918,101 | 108,414 | 3,213 | 197 | 761 | 1,030,686 |
| 2025 | 1,593,793 | 111,217 | 3,294 | 174 | 706 | 1,709,184 |
| 2026 (YTD) | 1,152,615 | 72,984 | 2,246 | 86 | 474 | 1,228,405 |
| All Time | 11,210,319 | 663,029 | 20,967 | 1,399 | 5,080 | 11,900,794 |
Strategic Implications & Recommendations for Commercial Fleets
The September 2026 FMCSA Drug and Alcohol Clearinghouse Report underscores a transformative era in commercial motor vehicle (CMV) safety and regulatory enforcement. With over 417,000 total violations recorded since January 2020 and 60.7% of impacted drivers remaining in a "Prohibited" status, the database continues to fulfill its primary mission: removing non-compliant drivers from the nation's highways.
Key takeaways for motor carriers, safety managers, and industry professionals include:
As FMCSA continues to integrate Clearinghouse data with state driver licensing agencies (SDLAs) to restrict CDL issuance and renewals for prohibited drivers, maintaining flawless compliance with query and violation reporting mandates remains paramount for all commercial fleets.
A: The driver is automatically placed in a "Prohibited" status in the Clearinghouse. Per federal regulations (49 C.F.R. § 382.501), the employer must immediately remove the driver from performing all safety-sensitive functions, including operating any Commercial Motor Vehicle (CMV).
A: A driver must complete the official 6-step Return-to-Duty (RTD) process mandated by 49 C.F.R. Part 40:
A: Although many US states have legalized medical or recreational marijuana, the U.S. Department of Transportation (DOT) operates under strict federal guidelines. Federal law classifies marijuana as a Schedule I controlled substance and mandates zero tolerance for CDL holders performing safety-sensitive duties, regardless of state legislation.
A: Yes. Motor carriers that fail to conduct required pre-employment full queries or annual limited queries face severe FMCSA civil penalties per violation, audit citations, and potential adjustments to their safety ratings.
Official Report Source: